LIVE

VKTX

Viking Therapeutics, Inc.

VKTX

NASDAQ·Healthcare·Biotechnology·Mkt cap $4.4B

$37.44

▼ -0.11%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$22.96 - $43.15

P/E

-9.04

Fwd P/E

-9.98

Beta

0.68

Div Yield

0.00%

Avg Vol

2.4M

Shares Out

115.9M

Mkt Cap

$4.4B

Price action

Price chart

Up 35.2% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

▲

Bull Case

4 reasons

  • Tissue-selective drug development
  • Targeted receptor agonist technologies
  • Diverse clinical-stage pipeline
  • Focused research in underserved medical markets
▼

Bear Case

1 risk

  • Low volatility (beta 0.7).

Growth

Revenue decline expected

Expanding metabolic disease treatment market

Value

Deep value opportunity - significant discount to Biotech & Therapeutics peers

Momentum

Strong

+7.7% over 3m

Quality

Loss-making

Below average quality

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Apr 21, 2026

“
Q2 26 RECAP

APR 29, 2026

Reported EPS of -$1.37 vs -$1.01 consensus (-35.6% surprise).

EPS miss

EPS surprise · last 4Q

0 of 1 beats

Q2 26

-35.6%

Next: Apr 21, 2026

Revenue trend · last 8Q

—

—

—

—

—

—

—

—

Q2 24

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

$0

$0

$0

$0

$0

$0

$0

$0

Margins · last 8Q

No margin history available.

View full earnings history →

Wall Street consensus

3 analysts · 100% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

3

100%

Hold

0%

Sell

0%

Median Price Target

$92.00

▲ +145.7% vs $37.44

Low $83.00
Median $92.00
High $100.00

Latest: Cantor Fitzgerald · Jul 1, 2026

4 analysts covering

View full analyst page →

vs Industry

How VKTX stacks vs Biotechnology

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.